Research and Markets: Influenza Vaccine Production & Distribution Market Brief

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/5df6x7/influenza_vaccine) has announced the addition of the "Influenza Vaccine Production & Distribution Market Brief" report to their offering.

'2014 Influenza Vaccine Production & Distribution Market Brief' presents key facts about the influenza season, including exclusive supply chain information from the annual Flu Products Survey.

The 2013-2014 influenza season was a moderately severe year, in which the influenza A (H3N2), 2009 influenza A (H1N1), and influenza B viruses circulated in the United States. The 2009 H1N1 viruses predominated most of the year, while the influenza B viruses came on stronger later in the season. The healthcare supply chain demonstrated flexibility and operational skill through 24-48 hour delivery and logistical expertise to ensure healthcare providers were well-supplied throughout the flu season.

Additionally, the 2014 Influenza Vaccine Production & Distribution market brief provides key information on:

- Flu vaccine production, supply, and allocation

- Patient and physician vaccination trends

- Managing influenza with diagnostic resources

- Manufacturing and distribution processes

- New data on sites for patient vaccination

- Medicare reimbursement guide

- Quality reporting measures related to influenza vaccination.

Who should read this report:

This report is intended for several key audiences: senior sales, marketing, and strategy executives of healthcare distribution and manufacturing companies, and healthcare sales staff in the field. Stakeholders in the influenza vaccine supply chain and government agencies responsible for the public health and oversight of the production and distribution of influenza vaccines will also find this report of interest.

Key Topics Covered:

  1. Executive summary
  2. Manufacturers plan to increase production to 157 million doses of flu vaccine
  3. Influenza vaccine production increases by almost 20 million doses
  4. Vaccine types available for patients, providers
  5. Flu vaccine demand strongest in fall
  6. Physician offices continue to be top site for vaccinations
  7. Flu products survey shows key role of distributors and increased
  8. distribution of rapid diagnostics
  9. Flu products survey
  10. Reimbursement guide for Medicare: 2014
  11. Quality Reporting Requires Flu Vaccination Documentation
  12. Managing influenza with diagnostic resources
  13. Appendix: Distribution's role in influenza vaccination

For more information visit http://www.researchandmarkets.com/research/5df6x7/influenza_vaccine

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases